Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae Producing Extended-Spectrum and AmpC type β-Lactamases

Journal of Microbiology, Immunology and Infection

Volumn 45, Issue 3, 2012, Pages 193-199

  Tsui, Kochung ^a,b   Wong, Swee Siang ^a   Lin, Li Chen ^a   Tsai, Chim Ren ^a   Chen, Li Chun ^a   Huang, Cheng Hua ^a,b  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

AmpC lactamase; Bacteremia; E coli; ESBL; K pneumoniae

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE AMPC; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEFTAZIDIME; QUINOLONE DERIVATIVE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CATHETER INFECTION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; INDWELLING CATHETER; INFECTION RISK; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NASOGASTRIC TUBE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

AGED; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CEFOTAXIME; CEFTAZIDIME; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHENOTYPE; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84861229692     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2011.11.003     Document Type: Article

References (24)

1. Pfaller M.A., Segreti J. Overview of the epidemiological profileand laboratory detection of extended-spectrum β-Lactamases. Clin Infect Dis 2006, 42:S153-S163.
2. Huemer H.P., Eigentler A., Aschbacher R., Larcher C. Dominance of CTX-M group 1 b-lactamase enzymes in ESBL-producing E. coli from outpatient urines in neighboring regions of Austria and Italy. Wiener Klinische Wochenschrift 2011, 123:41-44.
3. Simner P.J., Zhanel G.G., Pitout J., Tailor F., McCracken M., Mulvey M.R., et al. Prevalence and characterization of extended-spectrum b-lactamase- and AmpC b-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011, 69:335-341.
4. Su L.-H., Chu C., Cloeckaert A., Chiu C.-H. An epidemic of plasmids? Dissemination of extended-spectrum cephalosporinases among Salmonella and other Enterobacteriaceae. FEMS Immunol Med Microbiol 2008, 52:155-168.
5. Qi C., Pilla V., Yu J.H., Reed K. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum b -lactamases in outpatient urinary E. coli between 2003 and 2008. Diagn Microbiol Infect Dis 2010, 67:87-91.
6. Song W., Kim J.-S., Kim H.-S., Yong D., Jeong S.H., Park M.J., et al. Increasing trend in the prevalence of plasmid-mediated AmpC b -lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagn Microbiol Infect Dis 2006, 55:219-224.
7. Oteo J., Pérez-Vázquez M., Campos J. Extended-spectrum b -lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 2010, 23:320-326.
8. Robberts F.J.L., Kohner P.C., Patel R. unreliable extended-spectrum b -Lactamase detection in the presence of plasmid-mediated AmpC in Escherichia coli clinical Isolates. J Clin Microbiol 2009, 47:358-361.
9. Moland E.S., Hanson N.D., Black J.A., Hossain A., Song W., Thomson K.S. Prevalence of Newer b -Lactamases in Gram-negative clinical isolates collected in the United States from 2001 to 2002. J Clin Microbiol 2006, 44:3318-3324.
10. Ding H., Yang Y., Lu Q., Wang Y., Chen Y., Deng L., et al. The prevalence of plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China. Eur J Clin Microbiol Infect Dis 2008, 27:915-921.
11. Paterson D.L., Ko W.-C., Von Gottberg A., Casellas J.M., Mulazimoglu L., Klugman K.P., et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum b -Lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001, 39:2206-2212.
12. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. M100-S20 2010, Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA.
13. Yagi T., Wachino J.-i., Kurokawa H., Suzuki S., Yamane K., Doi Y., et al. Practical Methods using boronic acid compounds for identification of class C b -Lactamase-producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 2005, 43:2551-2558.
14. Saladin M., Cao V.T.B., Lambert T., Donay J.L., Herrmann J.L., Ould-Hocine Z., et al. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three parisian hospitals. FEMS Microbiol Lett 2002, 209:161-168.
15. Park Y.-J., Park S.Y., Oh E.-J., Park J.J., Lee K.Y., Woo G.J., et al. Occurrence of extended-spectrum b-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria. Diagn Microbiol Infect Dis 2005, 51:265-269.
16. Perez-Perez F.J., Hanson N.D. Detection of plasmid-mediated AmpC b-Lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
17. Pasteran F., Mendez T., Guerriero L., Rapoport M., Corso A. Sensitive Screening Tests for suspected class A Carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol 2009, 47:1631-1639.
18. Pasterán F., Rapoport M., Petroni A., Faccone D., Corso A., Galas M., et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob Agents Chemother 2006, 50:3222-3224.
19. Pasteran F., Faccone D., Petroni A., Rapoport M., Galas M., Vázquez M., et al. Novel Variant (blaVIM-11) of the Metallo- b -Lactamase blaVIM family in a GES-1 extended-spectrum- b -Lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Antimicrob Agents Chemother 2005, 49:474-475.
20. Corvec S., Crémet L., Caroff N., Dauvergne S., Le Floch R., Reynaud A., et al. Klebsiella pneumoniae clinical isolate coproducing SHV-2a, DHA-1, QnrB4, and AAC(6')-Ib-cr determinants in France. Diagn Microbiol Infect Dis 2009, 64:462-463.
21. Garrec H., Drieux-Rouzet L., Golmard J.-L., Jarlier V., Robert J. Comparison of Nine Phenotypic methods for detection of extended-spectrum b -Lactamase production by Enterobacteriaceae. J Clin Microbiol 2011, 49:1048-1057.
22. Lee C.-H., Su L.-H., Li C.-C., Chien C.-C., Tang Y.-F., Liu J.-W. Microbiologic and clinical implications of bacteremia due to extended-spectrum- b -Lactamase-Producing Klebsiella pneumoniae with or without plasmid-mediated AmpC b -Lactamase DHA-1. Antimicrob Agents Chemother 2010, 54:5395-5398.
23. Tan T.Y., Ng L.S., He J., Chen D.M. Improved detection of AmpC b -lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis using new susceptibility breakpoints for third-generation cephalosporins. Diagn Microbiol Infect Dis 2011, 70:423-424.
24. Wang P., Hu F., Xiong Z., Ye X., Zhu D., Wang Y.F., et al. Susceptibility of ESBL-producing Enterobacteriaceae with the new CLSI breakpoints. J Clin Microbiol 2011, 49:3127-3131.